ProQR Therapeutics (PRQR) Return on Assets (2014 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Return on Assets of 0.0% for Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and down 19.47% on a QoQ basis from 0.0% in Q4 2025.
ProQR Therapeutics (PRQR) Return on Assets (2014 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Return on Assets for 12 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets declined to 0.0% in Q1 2026 per PRQR's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Assets for PRQR reached as high as 0.0% in Q2 2024 and fell as low as 0.0% in Q3 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
- Year by year, Return on Assets stood at 0.0% in 2022, then soared by 52 bps to 0.0% in 2023, then advanced by 3 bps to 0.0% in 2024, then sank by 82 bps to 0.0% in 2025, then slipped by 19 bps to 0.0% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |